Jump to content

B25. Tumor markers of malignant ovarian cancer. Diagnosis and treatment of borderline ovarian cancer.: Difference between revisions

B25. Tumor markers of malignant ovarian cancer. Diagnosis and treatment of borderline ovarian cancer. (view source)

Revision as of 17:03, 6 August 2023

3,550 bytes added ,  6 August 2023
Created page with "== Tumour markers of malignant ovarian cancer == Tumour markers in ovarian cancer are not used for diagnosis but rather for preoperative evaluation and follow-up. They’re not appropriate for screening of the general population. Several biomarkers are available for ovarian cancer: * Typical for epithelial tumours ** CA 125 ** CEA ** HE4 (human epididymis protein 4) * Typical for germ cell tumours ** β-hCG ** AFP * Typical for granulosa cell tumours ** Inhibin B ** An..."
(Created page with "== Tumour markers of malignant ovarian cancer == Tumour markers in ovarian cancer are not used for diagnosis but rather for preoperative evaluation and follow-up. They’re not appropriate for screening of the general population. Several biomarkers are available for ovarian cancer: * Typical for epithelial tumours ** CA 125 ** CEA ** HE4 (human epididymis protein 4) * Typical for germ cell tumours ** β-hCG ** AFP * Typical for granulosa cell tumours ** Inhibin B ** An...")
(No difference)